July 27, 2017 9:23 AM ET

Pharmaceuticals

Company Overview of Shire Orphan Therapies GmbH

Key Executives for Shire Orphan Therapies GmbH

NameBoard RelationshipsTitleAge
Leonhard Terp 9 RelationshipsGeneral Manager and Member of The Supervisory Board--

Shire Orphan Therapies GmbH Board Members*

NameBoard RelationshipsPrimary CompanyAge
Leonhard Terp 9 RelationshipsShire Orphan Therapies GmbH--
Tatjana May 19 RelationshipsIndivior PLC52
Bertram Wiedenmann 9 RelationshipsShire Orphan Therapies GmbH--
Carl D. Johnson 9 RelationshipsShire Orphan Therapies GmbH--
Simon Campbell C.B.E, F.R.S, Ph.D. 91 RelationshipsKura Oncology, Inc.--
View All Board Members

Shire Orphan Therapies GmbH Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Nominating Committee Tatjana May19 Relationships1 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
427.8K
Bonus
449.6K
Total Short Term Compensation
612.3K
Total Value of Options
8.3M
Compensation as of Fiscal Year
Shire Orphan Therapies GmbH CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Abattis Bioceuticals Corp. Appoints Wei Ma to Oversee Export and Business Development in Asia
July 25, 2017 10:50 PM ET
Cue Biopharma, Inc. Appoints Mary Simcox as Vice President of Translational Biology
July 25, 2017 12:00 PM ET
Aerie Pharmaceuticals Announces Appointment of Richard A. Halprin as Director of Professional Affairs
July 25, 2017 10:30 AM ET
VANC Pharmaceuticals Inc. Appoints Mark Kunzli as Director of Pharmacy Solutions
July 25, 2017 6:52 AM ET
Veritas Pharma Inc. Appoints Peter Doig to its Advisory Board
July 24, 2017 11:23 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Shire Orphan Therapies GmbH, please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.